Vaxcyte, Inc.

Historical 13F Holders

Symbol
PCVX
CUSIP
92243G108
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 309 151 M $4.90 B
2025 Q1 334 145 M $5.86 B
2024 Q4 348 141 M $11.5 B
2024 Q3 355 137 M $15.7 B
2024 Q2 285 124 M $9.40 B
2024 Q1 273 122 M $8.30 B
2023 Q4 239 105 M $6.59 B
2023 Q3 214 101 M $5.17 B
2023 Q2 214 100 M $5.00 B
2023 Q1 202 84.1 M $3.15 B
2022 Q4 222 84.8 M $4.07 B
2022 Q3 137 61.0 M $1.47 B
2022 Q2 110 51.4 M $1.12 B
2022 Q1 92 49.9 M $1.20 B
2021 Q4 92 44.7 M $1.06 B
2021 Q3 81 43.2 M $1.10 B
2021 Q2 77 43.2 M $973 M
2021 Q1 78 44.9 M $886 M
2020 Q4 84 42.3 M $1.12 B
2020 Q3 61 37.8 M $1.86 B
2020 Q2 40 36.0 M $1.13 B